Advertisement
Singapore markets close in 6 minutes
  • Straits Times Index

    3,287.55
    -5.58 (-0.17%)
     
  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • FTSE 100

    8,096.41
    +56.03 (+0.70%)
     
  • Bitcoin USD

    63,803.87
    -2,732.48 (-4.11%)
     
  • CMC Crypto 200

    1,359.38
    -23.20 (-1.68%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Gold

    2,340.20
    +1.80 (+0.08%)
     
  • Crude Oil

    83.00
    +0.19 (+0.23%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • FTSE Bursa Malaysia

    1,570.53
    -0.95 (-0.06%)
     
  • Jakarta Composite Index

    7,157.95
    -16.58 (-0.23%)
     
  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

3 Biotech Stocks That Could Double in 2022

3 Biotech Stocks That Could Double in 2022

Here's why they picked Adicet Bio (NASDAQ: ACET), ChemoCentryx (NASDAQ: CCXI), and NRx Pharmaceuticals (NASDAQ: NRXP). ChemoCentryx launched the drug shortly after receiving approval in the U.S. Tavneos is also approved for use in Japan.